Rate My Professor Christopher Gentile

Gentile's research program investigates the physiological mechanisms underlying obesity-induced cardiovascular dysfunction, with a strong emphasis on the gut microbiome's role in cardiometabolic diseases including heart disease and diabetes. Utilizing a translational approach that integrates isolated cell cultures, animal models, and human clinical studies, his lab explores how dietary patterns influence vascular health via microbial interactions. Notable contributions include demonstrating that suppression of gut dysbiosis reverses Western diet-induced vascular dysfunction (Battson et al., 2018), that gut microbiota modulates cardiac ischemic tolerance and aortic stiffness in obesity (Battson et al., 2019), and that transplanting obesity-associated human gut microbiota to mice promotes vascular dysfunction and glucose intolerance (Trikha et al., 2021). Additional key works encompass the therapeutic potential of microbial metabolites like indole-3-propionic acid in reducing vascular stiffness (Lee et al., 2020) and the vascular benefits of SGLT2 inhibitors in metabolic syndrome models (Lee et al., 2018). Funded by the National Institutes of Health, including a K01 career development award investigating endoplasmic reticulum stress in obesity-related vascular pathology, Gentile's scholarship has advanced the intersection of nutrition, microbiology, and cardiovascular physiology.